IRIS - Res&Arch Institutional Research Information System - Research & Archive

PARNETTI, Lucilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.091
EU - Europa 8.631
AS - Asia 8.268
SA - Sud America 1.613
AF - Africa 166
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 13
Totale 30.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.853
SG - Singapore 3.762
IE - Irlanda 1.740
UA - Ucraina 1.422
BR - Brasile 1.393
HK - Hong Kong 1.287
IT - Italia 1.287
CN - Cina 1.191
RU - Federazione Russa 998
VN - Vietnam 984
SE - Svezia 751
DE - Germania 724
FI - Finlandia 526
KR - Corea 362
GB - Regno Unito 290
FR - Francia 229
CA - Canada 135
IN - India 114
TR - Turchia 105
AT - Austria 99
PL - Polonia 97
AR - Argentina 88
NL - Olanda 77
RO - Romania 77
JP - Giappone 68
BD - Bangladesh 62
CH - Svizzera 60
MX - Messico 59
ZA - Sudafrica 54
IQ - Iraq 53
UZ - Uzbekistan 47
BE - Belgio 46
CZ - Repubblica Ceca 45
ES - Italia 44
ID - Indonesia 42
CO - Colombia 24
EC - Ecuador 23
GR - Grecia 23
LT - Lituania 23
PK - Pakistan 23
EG - Egitto 20
PY - Paraguay 20
CL - Cile 18
MA - Marocco 18
VE - Venezuela 18
AE - Emirati Arabi Uniti 16
JO - Giordania 16
LB - Libano 15
SA - Arabia Saudita 14
KE - Kenya 13
AU - Australia 12
DZ - Algeria 12
NZ - Nuova Zelanda 12
PE - Perù 12
DK - Danimarca 11
EU - Europa 11
IR - Iran 10
AM - Armenia 9
HR - Croazia 9
NP - Nepal 9
TN - Tunisia 9
AZ - Azerbaigian 8
BG - Bulgaria 8
IL - Israele 8
JM - Giamaica 8
KZ - Kazakistan 8
UY - Uruguay 8
BO - Bolivia 7
AL - Albania 6
PA - Panama 6
PH - Filippine 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
CR - Costa Rica 5
MD - Moldavia 5
RS - Serbia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
BY - Bielorussia 4
GE - Georgia 4
KG - Kirghizistan 4
LV - Lettonia 4
OM - Oman 4
SN - Senegal 4
TH - Thailandia 4
AO - Angola 3
CI - Costa d'Avorio 3
CM - Camerun 3
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GM - Gambi 3
GT - Guatemala 3
HN - Honduras 3
IS - Islanda 3
MY - Malesia 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TJ - Tagikistan 3
BF - Burkina Faso 2
Totale 30.753
Salva come PNG Salva come JPEG
Città #
Singapore 2.466
Chandler 1.967
Dublin 1.739
Hong Kong 1.273
San Mateo 850
Jacksonville 746
Boardman 682
Ashburn 603
Santa Clara 503
Dong Ket 479
Altamura 474
Medford 408
Princeton 402
Perugia 357
Wilmington 357
Seoul 356
Lawrence 355
Moscow 331
Beijing 289
Ann Arbor 259
Des Moines 248
Los Angeles 240
Munich 228
Andover 184
Ho Chi Minh City 183
New York 153
Piscataway 138
Helsinki 128
Saint Petersburg 121
São Paulo 116
Hanoi 114
The Dalles 101
San Paolo di Civitate 94
Falls Church 93
Turku 93
Norwalk 73
Woodbridge 67
Brooklyn 64
Warsaw 64
Denver 62
Izmir 62
Tokyo 61
Nuremberg 60
Montreal 57
Redmond 54
Houston 53
Dallas 52
Frankfurt am Main 52
Chennai 51
Columbus 51
Orem 49
Stockholm 47
Rome 43
Brussels 42
Belo Horizonte 41
Chicago 41
Boston 40
London 40
Poplar 40
Shanghai 38
Atlanta 37
Bucharest 35
Johannesburg 35
Rio de Janeiro 35
Timisoara 35
Phoenix 34
Amsterdam 33
Toronto 32
Manchester 31
Vienna 30
Brasília 27
Curitiba 27
Redwood City 27
Campinas 25
Da Nang 25
San Francisco 25
Mexico City 24
Baghdad 23
Tashkent 23
Guangzhou 22
Seattle 22
Haiphong 21
Lappeenranta 21
Den Haag 20
Charlotte 19
Hefei 19
Lausanne 19
Milan 19
Olomouc 18
Auburn Hills 17
Fairfield 17
Falkenstein 17
Naples 17
Amman 15
Ankara 15
Fortaleza 15
Mumbai 15
Changsha 14
Frankfurt Am Main 14
Ninh Bình 14
Totale 19.367
Salva come PNG Salva come JPEG
Nome #
CSF and blood biomarkers for Parkinson's disease 173
Apopoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer’s disease and vascular dementia patients 154
A new assay for antiphospholipid antibodies in patient with ischemic stroke 152
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 139
102.Evolutionary trends in carotid atherosclerotic plaques: results of a two-year follow-up study using an ultrasound imaging system. 138
Platelet MAO-B activity and vitamin B12 in old age dementias. 136
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 136
a-D-Mannosidses in patients with familial Alzheimer's Disease 131
First-ever stroke and outcome in patients admitted to Perugia Stroke Unit:predictors for death, dependency, and recurrence of stroke within the first three months. 128
a-D-Mannosidases in patients with Alzheimer's disease 127
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 120
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 119
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 118
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 117
Swalloving dysfunction: neurovascolar- anatomical correlation. 115
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 110
Blood pressure and functional aspects of the aging brain. 110
Hippocampal epileptogenesis in autoimmune encephalitis 110
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 109
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 109
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 108
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 107
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 107
99mTc-HMPAO cerebral SPECT in cerebrovascular disease with and without dementia. 106
Cerebrospinal fluid biomarkers in Parkinson disease. 106
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 106
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 105
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 105
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. 105
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 105
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 104
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 104
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 104
A magnetization transfer study of mild and advanced Parkinson's disease. 104
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 103
Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome. 102
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 102
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. 102
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 102
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 101
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 101
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 100
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 100
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 100
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 100
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 99
Early admission to stroke unit influences clinical outcome 99
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 99
B-mode imaging and histomorphometric evaluation of carotid atherosclerosis. 99
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 99
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 98
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 98
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 97
Brain SPECT in the diagnosis of degenerative dementia. 97
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 97
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 97
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 96
Is multi-infarct dementia representative of vascular dementias? A retrospective study 96
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 96
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry 94
[Drinking-water and cardiovascular mortality]. 94
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 94
Lysosomal enzyme activities in human brain 94
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 94
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 94
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 94
Cerebrospinal fluid biomarkers and white matter lesions: can we know more? 93
Association between migraine and headache attributed to stroke: a case-control study. 93
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 93
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 92
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 92
Atrial fibrillation and stroke. 91
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. 91
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 91
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 91
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 91
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. 90
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 90
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia 90
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 90
Vascular cognitive impairment: a pragmatic concept 89
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 89
Free water elimination improves test–retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects 89
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 89
Phospholipid autoantibodies: time for a new immuno-assay? 88
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. 88
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 88
Amyloid-β: a potential link between epilepsy and cognitive decline 88
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 87
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type. 87
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 87
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 86
[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases]. 86
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 86
Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers 86
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 86
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 86
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction 85
Magnetization transfer MRI in dementia disorders, Huntington's disease and parkinsonism 85
Biomarkers in Parkinson's disease: From pathophysiology to early diagnosis 85
Totale 10.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.728
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.619 0 0 0 0 0 137 202 39 340 123 240 538
2021/20223.192 80 580 88 141 96 85 53 944 100 131 372 522
2022/20236.532 437 1.297 81 564 491 799 15 271 2.295 18 197 67
2023/20242.424 184 280 126 59 27 14 463 97 273 99 397 405
2024/20256.102 86 606 234 283 761 351 191 456 1.231 417 995 491
2025/20267.658 1.032 1.005 782 1.935 1.889 1.015 0 0 0 0 0 0
Totale 31.664